stage ivb rectal cancer
Showing 1 - 18 of 18
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Tool in Patients With Metastatic Colorectal Cancer
Completed
- Stage IVA Colon Cancer
- +3 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Anchorage, Alaska
- +536 more
May 5, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Comprehensive Gene Sequencing in Guiding Treatment
Completed
- Recurrent Breast Cancer
- +7 more
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIA Colon Cancer Trial in Cleveland (positron emission tomography,
Completed
- Recurrent Colon Cancer
- +17 more
- positron emission tomography
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Apr 26, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
Liver Metastases, Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum Trial in Philadelphia
Terminated
- Liver Metastases
- +10 more
- irinotecan-eluting beads
- hepatic artery embolization
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 22, 2018
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in Duarte (MEK inhibitor MEK162, leucovorin
Completed
- Recurrent Colon Cancer
- +5 more
- MEK inhibitor MEK162
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 23, 2018
Recurrent Colon Carcinoma, Recurrent Rectal Carcinoma, Stage IVA Colon Cancer Trial in Seattle (drug, radiation, other,
Terminated
- Recurrent Colon Carcinoma
- +5 more
- Capecitabine
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 14, 2017
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Rochester, New York, Columbus (FOLFOX
Withdrawn
- Adenocarcinoma of the Colon
- +7 more
- FOLFOX regimen
- +5 more
-
Rochester, Minnesota
- +2 more
Apr 3, 2017
Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Buffalo (Fluorouracil, Irinotecan
Withdrawn
- Colon Adenocarcinoma
- +16 more
- Fluorouracil
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 19, 2016
Depressive Symptoms, Fatigue, Psychosocial Effects of Cancer and Its Treatment Trial in Nashville (Yoga Skills Training (YST),
Completed
- Depressive Symptoms
- +18 more
- Yoga Skills Training (YST)
- +5 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 19, 2015
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIIA Colon Cancer Trial in Los Angeles (ispinesib, laboratory biomarker
Completed
- Recurrent Colon Cancer
- +11 more
- ispinesib
- laboratory biomarker analysis
-
Los Angeles, CaliforniaUniversity of Southern California, Norris
Feb 13, 2015
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer Trial in United States (irinotecan HCl, leucovorin
Terminated
- Recurrent Colon Cancer
- +5 more
- irinotecan hydrochloride
- +4 more
-
Ft. Smith, Arkansas
- +381 more
Jul 25, 2014
Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Baltimore
Completed
- Mucinous Adenocarcinoma of the Colon
- +15 more
- erlotinib hydrochloride
- +4 more
-
Baltimore, MarylandJohns Hopkins University
Sep 27, 2013
Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Rochester
Completed
- Mucinous Adenocarcinoma of the Colon
- +15 more
- irinotecan hydrochloride
- +4 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
May 1, 2013
Male Breast Cancer, Stage IV Breast Cancer, Stage IV Melanoma Trial in Boston (cediranib maleate, whole-brain radiation therapy)
Terminated
- Male Breast Cancer
- +9 more
- cediranib maleate
- whole-brain radiation therapy
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Mar 7, 2013
Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in New York
Terminated
- Mucinous Adenocarcinoma of the Colon
- +9 more
- fluorouracil
- +3 more
-
New York, New YorkMount Sinai Medical Center
Jan 31, 2013